The objective of this research is to explore the effects of hormone therapy using testosterone on pelvic floor dysfunction (PFD) in transgender men. We hypothesize that PFD might be prevalent among transgender men undergoing hormone therapy. Therefore, this study was aimed at verifying the frequency of these dysfunctions.
Results
A total of 68 transgender men were included. Most participants had storage symptoms (69.1%), sexual dysfunction (52.9%), anorectal symptoms (45.6%), and flatal incontinence (39.7%). Participants with UI symptoms reported moderate severity of the condition.
Conclusions
Transgender men on hormone therapy have a high incidence of PFD (94.1%) and experience a greater occurrence of urinary symptoms (86.7%).
Well, what would one expect when carving up genitals to conform to the new fashion?
I have no idea what the sexual function of either sex is once the surgeons have finished playing with them.
And they are not ‘trans men’ they are women and they are not ‘trans women’ they are men.
We are so obsessed with the mutation of language used to describe the mutilation of healthy young women and men.
We shall look back on this epoch and shudder…